Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» depression
depression
AbbVie bets $130M on UCB spinout, bagging early-phase Alzheimer's and depression prospect
Fierce Biotech
Tue, 03/1/22 - 10:42 am
AbbVie
M&A
Neuroscience
Syndesi Therapeutics
UCB Pharma
Alzheimer's disease
depression
Sage claims new data show depression drug works, but doubts remain
Biopharma Dive
Wed, 02/16/22 - 11:05 pm
SAGE Therapeutics
Biogen
depression
clinical trials
zuranolone
Sage changes primary endpoint in key study months after analysts fret about depression drug's durability
Endpoints
Wed, 11/3/21 - 10:41 am
SAGE Therapeutics
clinical trials
zuranolone
depression
endpoints
SSRIs
Axsome sees depression drug decision delayed as FDA kicks expected CRL can down the road
Fierce Biotech
Mon, 08/23/21 - 11:08 am
Axsome Therapeutics
depression
FDA
Go or no go? August FDA decisions for Axsome, Sanofi and Merck
EP Vantage
Fri, 07/30/21 - 11:04 am
FDA
Axsome Therapeutics
Sanofi
Merck
Pompe disease
depression
kidney cancer
Keytruda
Could These 3 Potential Blockbusters Transform Biogen?
Motley Fool
Mon, 07/26/21 - 09:04 am
Biogen
zuranolone
depression
TMS-007
stroke
Aduhelm
Alzheimer's disease
Sage Therapeutics Plunges After Depression Drug-Trial Results
TheStreet.com
Tue, 06/15/21 - 10:36 am
SAGE Therapeutics
clinical trials
depression
Biogen
zuranolone
FDA Begins Priority Review of Axsome Therapeutics' Potential New Depression Drug
Motley Fool
Mon, 04/26/21 - 11:07 pm
Axsome Therapeutics
depression
AXS-05
First-of-its-kind study pits psilocybin against a common antidepressant
Stat
Wed, 04/14/21 - 09:45 pm
psilocybin
psychedelic drugs
depression
antidepressants
Is Biogen Getting Desperate?
Motley Fool
Wed, 12/9/20 - 10:42 am
Biogen
SAGE Therapeutics
major depressive disorder
depression
Biogen bets $1.5B on Sage's once-failed depression drug
Fierce Biotech
Mon, 11/30/20 - 10:29 am
Biogen
SAGE Therapeutics
zuranolone
depression
Google’s sister company didn’t succeed in search for depression biomarker
MedCity News
Thu, 11/5/20 - 10:56 am
Google X
Alphabet
depression
biomarkers
R&D
Praxis raises $110M to advance 3 clinical-phase CNS drugs
Fierce Biotech
Tue, 07/28/20 - 10:48 am
Praxis Precision Medicines
GABAA positive allosteric modulator
depression
Orexo launches digital therapies for depression, alcohol misuse early in US
Pharmaforum
Fri, 07/17/20 - 10:46 am
Orexo
digital therapies
COVID-19
depression
alcoholism
FDA List Notes Drug Shortages Related to Intubation, Anxiety and Depression
BioSpace
Thu, 06/11/20 - 11:09 am
FDA
drug shortages
anxiety
depression
intubation
There May Be a New First-Line Treatment for Depression
Motley Fool
Thu, 04/30/20 - 10:37 am
Axsome Therapeutics
FDA
depression
AXS-05
Sage to lay off half of workforce in cost-cutting retrenchment
BioPharma Dive
Tue, 04/7/20 - 07:47 pm
SAGE Therapeutics
layoffs
depression
Zulresso
LivaNova and Verily in Research Agreement to Treat Depression
Medical Devices and Diagnostics Industry
Thu, 02/27/20 - 11:30 pm
LivaNova
Verily
Alphabet
vagus nerve stimulation
depression
devices
Sage rethinks SAGE-217 program after phase 3 failure
Fierce Biotech
Thu, 02/27/20 - 10:32 am
SAGE Therapeutics
clinical trials
depression
SAGE-217
Fisher Wallace files citizen petition over FDA’s class III designation for CES
BioWorld
Fri, 02/21/20 - 12:01 am
Fisher Wallace Labs
citizen petitions
FDA
cranial electrotherapy stimulation
depression
devices
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »